Dr. Merriam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-5204Fax+1 617-632-3408
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2013
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
- CT State Medical License 2022 - 2025
- MA State Medical License 2013 - 2025
- ME State Medical License 2022 - 2025
- NH State Medical License 2023 - 2025
- RI State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola
Clinical Cancer Research. 2024-07-01 - 3 citationsImage-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.Emmy Y Hu, Sharath K Bhagavatula, Andy Shi, Priscilla Merriam, Vincent M Levesque
Abdominal Radiology. 2024-04-01 - 5 citationsPhase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska
Clinical Cancer Research. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: